[HTML][HTML] Clinical characteristics of coronavirus disease 2019 in China
…, S Qiu, J Luo, C Ye, S Zhu, N Zhong - New England journal …, 2020 - Mass Medical Soc
Background Since December 2019, when coronavirus disease 2019 (Covid-19) emerged in
Wuhan city and rapidly spread throughout China, data have been needed on the clinical …
Wuhan city and rapidly spread throughout China, data have been needed on the clinical …
Effect of carbocisteine on acute exacerbation of chronic obstructive pulmonary disease (PEACE Study): a randomised placebo-controlled study
…, JZ Yuan, BT Yuan, HP Qian, RC Zhi, NS Zhong - The Lancet, 2008 - thelancet.com
Background Chronic obstructive pulmonary disease (COPD) is characterised by airflow
limitation, and has many components including mucus hypersecretion, oxidative stress, and …
limitation, and has many components including mucus hypersecretion, oxidative stress, and …
Impact of air pollution on the burden of chronic respiratory diseases in China: time for urgent action
WJ Guan, XY Zheng, KF Chung, NS Zhong - The Lancet, 2016 - thelancet.com
In China, where air pollution has become a major threat to public health, public awareness
of the detrimental effects of air pollution on respiratory health is increasing—particularly in …
of the detrimental effects of air pollution on respiratory health is increasing—particularly in …
Rapid development of SARS-CoV-2 spike protein receptor-binding domain self-assembled nanoparticle vaccine candidates
…, XW Kong, QY Zhu, Q Zhong, M Xu, NS Zhong… - ACS …, 2021 - ACS Publications
The coronavirus disease pandemic of 2019 (COVID-19) caused by the novel SARS-CoV-2
coronavirus resulted in economic losses and threatened human health worldwide. The …
coronavirus resulted in economic losses and threatened human health worldwide. The …
Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial
…, M Sardina, Y Gao, BS Wang, NS Zhong - The Lancet …, 2014 - thelancet.com
Background Increased oxidative stress and inflammation has a role in the pathogenesis of
chronic obstructive pulmonary disease (COPD). Drugs with antioxidant and anti-inflammatory …
chronic obstructive pulmonary disease (COPD). Drugs with antioxidant and anti-inflammatory …
[HTML][HTML] Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis
…, F Ye, S Li, J Zheng, N Zhang, N Zhong… - European …, 2020 - Eur Respiratory Soc
… Author contributions: Wei-jie Guan, Wen-hua Liang, Jian-xing He, and Nan-shan Zhong
participated in study design and study conception; Wen-hua Liang, Yi Zhao, Heng-rui Liang, Zi-…
participated in study design and study conception; Wen-hua Liang, Yi Zhao, Heng-rui Liang, Zi-…
[HTML][HTML] Clinical characteristics of 2019 novel coronavirus infection in China
…, G Li, Z Zheng, S Qiu, J Luo, C Ye, S Zhu, N Zhong - MedRxiv, 2020 - medrxiv.org
Background Since December 2019, acute respiratory disease (ARD) due to 2019 novel
coronavirus (2019-nCoV) emerged in Wuhan city and rapidly spread throughout China. We …
coronavirus (2019-nCoV) emerged in Wuhan city and rapidly spread throughout China. We …
[HTML][HTML] Clinical findings in 111 cases of influenza A (H7N9) virus infection
…, BM Hou, ZX Feng, JF Sheng, NS Zhong… - … England Journal of …, 2013 - Mass Medical Soc
Background During the spring of 2013, a novel avian-origin influenza A (H7N9) virus emerged
and spread among humans in China. Data were lacking on the clinical characteristics of …
and spread among humans in China. Data were lacking on the clinical characteristics of …
[HTML][HTML] Clinical characteristics and outcomes of hospitalised patients with COVID-19 treated in Hubei (epicentre) and outside Hubei (non-epicentre): a nationwide …
…, F Ye, S Li, J Zheng, N Zhang, N Zhong… - European …, 2020 - Eur Respiratory Soc
Background During the outbreak of coronavirus disease 2019 (COVID-19), consistent and
considerable differences in disease severity and mortality rate of patients treated in Hubei …
considerable differences in disease severity and mortality rate of patients treated in Hubei …
Distinct features of SARS-CoV-2-specific IgA response in COVID-19 patients
…, X Liu, Y Li, X Sun, H Liang, B Zhong… - European …, 2020 - Eur Respiratory Soc
… -gang Liu and Nan-shan Zhong participated in the study design. Hong-feng Liang, Bei Zhong,
Zhi-… Nan-shan Zhong and Zhi-gang Liu critically reviewed and revised the manuscript. All …
Zhi-… Nan-shan Zhong and Zhi-gang Liu critically reviewed and revised the manuscript. All …